Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andreas, Kulozik"'
Autor:
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp-Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas Kulozik, Joachim Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-17 (2023)
Abstract Background Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2 invest
Externí odkaz:
https://doaj.org/article/26e8df351a78481d84b79ca3e21d57c8
Autor:
Stefanie V. Junk, Elke Schaeffeler, Martin Zimmermann, Anja Möricke, Rita Beier, Peter Schütte, Birthe Fedders, Julia Alten, Laura Hinze, Norman Klein, Andreas Kulozik, Martina U. Muckenthaler, Rolf Koehler, Arndt Borkhardt, Jayaram Vijayakrishnan, David Ellinghaus, Michael Forster, Andre Franke, Astrid Wintering, Christian P. Kratz, Martin Schrappe, Matthias Schwab, Richard S. Houlston, Gunnar Cario, Martin Stanulla
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-15 (2023)
Abstract Background Characterization of clinical phenotypes in context with tumor and host genomic information can aid in the development of more effective and less toxic risk-adapted and targeted treatment strategies. To analyze the impact of therap
Externí odkaz:
https://doaj.org/article/9a13023e87354932b2b585a4703304a8
Autor:
Anja Möricke, Carmelo Rizzari, Julia Alten, Andishe Attarbaschi, Rita Beier, Andrea Biondi, Birgit Burkhardt, Nicole Bodmer, Joachim Boos, Gunnar Cario, Valentino Conter, Christian Flotho, Andreas Kulozik, Claudia Lanvers-Kaminsky, Georg Mann, Felix Niggli, Daniela Silvestri, Arend von Stackelberg, Martin Stanulla, Maria-Grazia Valsecchi, Martin Schrappe, Martin Zimmermann
Publikováno v:
HemaSphere, Vol 7, Iss 6, p e888 (2023)
Externí odkaz:
https://doaj.org/article/1f57053bb60c4f92992766869d084c51
Autor:
Dimitrios Farmakis, John Porter, Ali Taher, Maria Domenica Cappellini, Michael Angastiniotis, Androulla Eleftheriou, for the 2021 TIF Guidelines Taskforce, Ali Alassaf, Emanuele Angelucci, Yesim Aydinok, Rayan Bou-Fakhredin Rayan, Loris Brunetta, George Constantinou, Shahina Daar, Vincenzo De Sanctis, Geoffrey Dusheiko, Riyad Elbard, Perla Eleftheriou, Panos Englezos, Dru Haines, Faiez N Hattab, George Kaltsounis, Antonios Kattamis, John Koskinas, Navdeep Kumar, Andreas Kulozik, Andreas Kyriakou, Aurelio Maggio, Roanna Maharai, Lauren Mednick, Eleni Michalaki, Wendy Murphy, Lena Oevermann, Raffaella Origa, Penelope-Georgia Papayanni, Constantina Politis, Farukh Shah, Anton Skafi, Nikos Skordis, Pietro Sodani, Ashraf Soliman, Seni Subair, Maria Tampaki, Sara Trompeter, Shobha Tuli, Malcolm Walker, Robert Yamashita, Evangelia Yannaki, Anne Yardumian
Publikováno v:
HemaSphere, Vol 6, Iss 8, p e732 (2022)
Beta-thalassemia and particularly its transfusion-dependent form (TDT) is a demanding clinical condition, requiring life-long care and follow-up, ideally in specialized centers and by multidisciplinary teams of experts. Despite the significant progre
Externí odkaz:
https://doaj.org/article/e09c27ab622646e18fe28c7d0ec0779e
Autor:
Carole Trzaska, Séverine Amand, Christine Bailly, Catherine Leroy, Virginie Marchand, Evelyne Duvernois-Berthet, Jean-Michel Saliou, Hana Benhabiles, Elisabeth Werkmeister, Thierry Chassat, Romain Guilbert, David Hannebique, Anthony Mouray, Marie-Christine Copin, Pierre-Arthur Moreau, Eric Adriaenssens, Andreas Kulozik, Eric Westhof, David Tulasne, Yuri Motorin, Sylvie Rebuffat, Fabrice Lejeune
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nonsense mutations can be corrected by several molecules that activate readthrough of premature termination codon. Here, the authors report that 2,6-diaminopurine efficiently corrects UGA nonsense mutations with no significant toxicity.
Externí odkaz:
https://doaj.org/article/970f33637b174d7ca2db00d47c85ff08
Autor:
Achille Iolascon, Immacolata Andolfo, Roberta Russo, Wilma Barcellini, Elisa Fermo, Gergely Toldi, Stefano Ghirardello, Davis Rees, Richard Van Wijk, Antonis Kattamis, Patrick G. Gallagher, Noemi Roy, Ali Taher, Razan Mohty, Andreas Kulozik, Lucia De Franceschi, Antonella Gambale, Mariane De Montalembert, Gian Luca Forni, Cornelis L. Harteveld, Josef Prchal, Paola Bianchi, on behalf of SWG of Red Cell and Iron of EHA and EuroBloodNet
Publikováno v:
HemaSphere, Vol 5, Iss 12, p e660 (2021)
Externí odkaz:
https://doaj.org/article/fa52406ab7464209b23b224ac22e0faf
Autor:
Roland Imle, Georgi Tosev, Wolfgang Behnisch, Jens-Peter Schenk, Helmut Rauch, Andreas Mueller, Matthias Gorenflo, Tsvetomir Loukanov, Andreas Kulozik, Joanne Nyarangi-Dix
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 33-38 (2019)
While Wilms tumors (WT) typically present solely with an abdominally palpable mass, rare cases exhibiting vascular tumor growth can also present with circulatory problems. Here, we report the case of a 2.5-year-old girl presenting with upper venous c
Externí odkaz:
https://doaj.org/article/b3ce40956a114610a98e9f7a772fa79b
Autor:
Tamara Kempter, Paulina Richter-Pechanska, Katarzyna Michel, Tobias Rausch, Busra Erarslan-Uysal, Cornelia Eckert, Martin Zimmermann, Martin Stanulla, Martin Schrappe, Gunnar Cario, Stefan Köhrer, Renate Kirschner-Schwabe, Jan Korbel, Joachim Kunz, Andreas Kulozik
It has been the hypothesis of this study that clonal or subclonal variants of TP53 and KRAS that signify ultra-high risk in relapsed pediatric T-ALL indicate a poor prognosis at initial disease. We analyzed two cohorts of 160 and 226 BFM-patients, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccfa2ba3f5c1a8b15c020652413b79d4
https://doi.org/10.21203/rs.3.rs-2637710/v1
https://doi.org/10.21203/rs.3.rs-2637710/v1
Autor:
Stefanie Junk, Elke Schaeffeler, Martin Zimmermann, Anja Möricke, Rita Beier, Peter Schütte, Birthe Fedders, Julia Alten, Laura Hinze, Norman Klein, Andreas Kulozik, Martina Muckenthaler, Rolf Koehler, Arndt Borkhardt, Jayaram Vijayakrishnan, David Ellinghaus, Michael Forster, Andre Franke, Astrid Wintering, Christian Kratz, Martin Schrappe, Matthias Schwab, Richard Houlston, Gunnar Cario, Martin Stanulla
Background Characterization of clinical phenotypes in context with tumor and host genomic information can aid in the development of more effective and less toxic risk-adapted and targeted treatment strategies. To analyze the impact of therapy-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dea6150bdd3c4dad2748b61aacb46e
https://zenodo.org/record/7539533
https://zenodo.org/record/7539533
Autor:
Joachim Kunz, Andreas Kulozik
Publikováno v:
Pädiatrie ISBN: 9783662602997
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14a53d65959ebbb06e66e41b15a73d67
https://doi.org/10.1007/978-3-662-60300-0_216
https://doi.org/10.1007/978-3-662-60300-0_216